Community carriage of ESBL-producing Escherichia coli and Klebsiella pneumoniae: a cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates

被引:10
|
作者
Raffelsberger, Niclas [1 ,2 ]
Buczek, Dorota Julia [2 ]
Svendsen, Kristian [3 ]
Smabrekke, Lars [3 ]
Pontinen, Anna Kaarina H. [4 ,5 ]
Lohr, Iren [6 ]
Andreassen, Lotte Leonore Eivindsdatter [1 ]
Simonsen, Gunnar Skov [1 ,2 ]
Sundsfjord, Arnfinn [2 ,4 ]
Gravningen, Kirsten [1 ,7 ,8 ]
Samuelsen, Orjan [3 ,4 ]
机构
[1] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway
[2] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, Tromso, Norway
[3] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Tromso, Norway
[4] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway
[5] Univ Oslo, Dept Biostat, Oslo, Norway
[6] Stavanger Univ Hosp, Dept Med Microbiol, Stavanger, Norway
[7] Akershus Univ Hosp, Dept Microbiol & Infect Control, Nordbyhagen, Norway
[8] Univ Oslo, Inst Clin Med, Div Med & Lab Sci, Oslo, Norway
关键词
Escherichia coli; Klebsiella pneumoniae; extended-spectrum beta-lactamase; antimicrobial resistance; carriage; risk factors; general population; bacterial genomics; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; BLOOD-STREAM INFECTIONS; FECAL COLONIZATION; PREVALENCE; NORWAY; RESISTANCE; NATIONWIDE; EMERGENCE; MORTALITY; THERAPY;
D O I
10.1128/msphere.00025-23
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The global prevalence of infections caused by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) is increasing, and for Escherichia coli, observations indicate that this is partly driven by community-onset cases. The ESBL-E population structure in the community is scarcely described, and data on risk factors for carriage are conflicting. Here, we report the prevalence and population structure of fecal ESBL-producing E. coli and Klebsiella pneumoniae (ESBL-Ec/Kp) in a general adult population, examine risk factors, and compare carriage isolates with contemporary clinical isolates. Fecal samples obtained from 4,999 participants (54% women) >= 40 years in the seventh survey of the population-based Tromso Study, Norway (2015, 2016), were screened for ESBL-Ec/Kp. In addition, we included 118 ESBL-Ec clinical isolates from the Norwegian surveillance program in 2014. All isolates were whole-genome sequenced. Risk factors associated with carriage were analyzed using multivariable logistic regression. ESBL-Ec gastrointestinal carriage prevalence was 3.3% [95% confidence interval (CI) 2.8%-3.9%, no sex difference] and 0.08% (0.02%-0.20%) for ESBL-Kp. For ESBL-Ec, travel to Asia was the only independent risk factor (adjusted odds ratio 3.46, 95% CI 2.18-5.49). E. coli ST131 was most prevalent in both collections. However, the ST131 proportion was significantly lower in carriage (24%) versus clinical isolates (58%, P < 0.001). Carriage isolates were genetically more diverse with a higher proportion of phylogroup A (26%) than clinical isolates (5%, P < 0.001), indicating that ESBL gene acquisition occurs in a variety of E. coli lineages colonizing the gut. STs commonly related to extraintestinal infections were more frequent in clinical isolates also carrying a higher prevalence of antimicrobial resistance, which could indicate clone-associated pathogenicity. IMPORTANCE ESBL-Ec and ESBL-Kp are major pathogens in the global burden of antimicrobial resistance. However, there is a gap in knowledge concerning the bacterial population structure of human ESBL-Ec/Kp carriage isolates in the community. We have examined ESBL-Ec/Kp isolates from a population-based study and compared these to contemporary clinical isolates. The large genetic diversity of carriage isolates indicates frequent ESBL gene acquisition, while those causing invasive infections are more clone dependent and associated with a higher prevalence of antibiotic resistance. The knowledge of factors associated with ESBL carriage helps to identify patients at risk to combat the spread of resistant bacteria within the healthcare system. Particularly, previous travel to Asia stands out as a major risk factor for carriage and should be considered in selecting empirical antibiotic treatment in critically ill patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study
    Akenten, Charity Wiafe
    Khan, Neyaz Ahmed
    Mbwana, Joyce
    Krumkamp, Ralf
    Fosu, Dennis
    Paintsil, Ellis Kobina
    Boahen, Kennedy Gyau
    Osei-Mensa, James
    Maiga-Ascofare, Oumou
    May, Juergen
    Obiri-Danso, Kwasi
    Phillips, Richard Odame
    Ofori, Linda Aurelia
    Dekker, Denise
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2023, 12 (01)
  • [2] Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study
    Charity Wiafe Akenten
    Neyaz Ahmed Khan
    Joyce Mbwana
    Ralf Krumkamp
    Dennis Fosu
    Ellis Kobina Paintsil
    Kennedy Gyau Boahen
    James Osei-Mensa
    Oumou Maiga-Ascofare
    Jürgen May
    Kwasi Obiri-Danso
    Richard Odame Phillips
    Linda Aurelia Ofori
    Denise Dekker
    Antimicrobial Resistance & Infection Control, 12
  • [3] Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in a population of Dutch travellers: A cross-sectional study
    Arcilla, Maris S.
    Van Hattem, Jarne M.
    Bootsma, Martin C. J.
    van Genderen, Perry J. J.
    Goorhuis, Abraham
    Grobusch, Martin P.
    Klaassen, Corne H. W.
    Lashof, Astrid M. Oude
    Schultsz, Constance
    Stobberingh, Ellen E.
    de Jong, Menno D.
    Penders, John
    Verbrugh, Henri A.
    Melles, Damian C.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 33
  • [4] The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community
    Bezabih, Yihienew M.
    Sabiiti, Wilber
    Alamneh, Endalkachew
    Bezabih, Alamneh
    Peterson, Gregory M.
    Bezabhe, Woldesellassie M.
    Roujeinikova, Anna
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (01) : 22 - 29
  • [5] Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study
    Ny, Sofia
    Lofmark, Sonja
    Borjesson, Stefan
    Englund, Stina
    Ringman, Maj
    Bergstrom, Jakob
    Naucler, Pontus
    Giske, Christian G.
    Byfors, Sara
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (02) : 582 - 588
  • [6] Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates
    Tan, Karen
    Nguyen, James
    Nguyen, Kevin
    Huse, Holly K.
    Nieberg, Paul H.
    Wong-Beringer, Annie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1506 - 1512
  • [7] Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study
    Isendahl, Joakim
    Turlej-Rogacka, Agata
    Manjuba, Cristovao
    Rodrigues, Amabelia
    Giske, Christian G.
    Naucler, Pontus
    PLOS ONE, 2012, 7 (12):
  • [8] ESBL-producing Escherichia coli and Klebsiella pneumoniae: The most prevalent clinical isolates obtained between 2005 and 2012 in Mexico
    Barrios, Humberto
    Garza-Ramos, Ulises
    Mejia-Miranda, Ilse
    Reyna-Flores, Fernando
    Sanchez-Perez, Alejandro
    Mosqueda-Garcia, Dalila
    Silva-Sanchez, Jesus
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 10 : 243 - 246
  • [9] ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands
    Meijs, Anouk P.
    Gijsbers, Esther F.
    Hengeveld, Paul D.
    Dierikx, Cindy M.
    de Greeff, Sabine C.
    van Duijkeren, Engeline
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2021, 10 (01)
  • [10] ESBL/pAmpC-producing Escherichia coli and Klebsiella pneumoniae carriage among veterinary healthcare workers in the Netherlands
    Anouk P. Meijs
    Esther F. Gijsbers
    Paul D. Hengeveld
    Cindy M. Dierikx
    Sabine C. de Greeff
    Engeline van Duijkeren
    Antimicrobial Resistance & Infection Control, 10